Diffuse punctate keratitis in a patient treated with cetuximab as monotherapy [3]

Annals of Oncology

Volumn 18, Issue 5, 2007, Pages 961-962

  Specenier, Pol ^a   Koppen, C ^a   Vermorken, J B ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; HYALURONIC ACID;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG RESPONSE; DRUG WITHDRAWAL; EYE PHOTOGRAPHY; HUMAN; LETTER; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OROPHARYNX CANCER; PRIORITY JOURNAL; PUNCTATE KERATITIS; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 34447324112     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm116     Document Type: Letter

References (5)

1. Lu L, Reinach PS, Kao WW-Y. Corneal epithelial wound healing. Exp Biol Med 2001; 226: 653-664
2. Nakamura Y, Sotozono C, Kinoshita S. The epidermal growth Factor Receptor (EGFR): Role in corneal wound healing and homeostasis. Exp Eye Res 2001; 72: 511-517.
3. Xu KP, Riggs A, Ding Y, Yu FS. Role of ErB2 in cornea epithelial wound healing Invest Ophthalmol Vis Sci 2004; 45: 4277-4283.
4. Shah NT, Kris MG, Pao W et al. Practical management of patients with non-small-cell lung cancer treated with gefitinib. J Clin Oncol 2005; 23: 165-174.
5. Dueland S, Sauer T, Lund-Johansen F, Ostenstad D, Tveit KM. epidermal growth factor inhibition induces trichomegaly. Acta Oncol 2003; 42: 345-346.